Skip to main content

DCAT: From the podium 

With over 10,000 industry professional attendees, this year’s DCAT Week, held from 19-23 March in New York, was the event’s biggest yet. At the DCAT Member Company Announcement Forum, it was clear that the seemingly unceasing trend for mergers and acquisitions continues to gather pace.

Healthcare at the push of a button

Wearable technology, trackable medicine, embedded body scanners: are these technologies the future of the healthcare industry? At CPhI North America, digital technology experts Dr Bertalan Mesko and Nik Leist will discuss this and more. They spoke to Speciality Chemicals Magazine ahead of the event

International investor influx in Southeast Asia

Geopolitical stability, gradually rising living standards and the introduction of universal healthcare systems is fuelling investor interest across Southeast Asia, particularly in Indonesia, which is home to the largest and fastest growing market.

Merck expands in Asia and proposes to acquire Australia’s Viralytics

Leading science and technology company Merck (known as MilliporeSigma in the US) has announced agreements in China, India and South Korea that will see the company invest €40 million in the region.

The company has signed an agreement with Incheon Free Economic Zone (IFEZ) to build an integrated cell culture facility in Songdo, Incheon. Located on 10,141m2 of land, the new centre will include cell culture media facilities and a logistics infrastructure. Construction is expected to begin in May 2018 and to be completed by mid-2019.

Subscribe to Pharmaceuticals

 

 

AMRI web banner